P15813 (CD1D_HUMAN) Homo sapiens (Human)
Antigen-presenting glycoprotein CD1d UniProtKBInterProSTRINGInteractive Modelling
335 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
19 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal structure of human TCR Alpha Chain-TRAV21-TRAJ8, Beta Chain-TRBV7-8, Antigen-presenting gly… |
Heteromer A0A0B4J279; A0A5B9; P01848; P61769; | 2×NAG; 1×JLS; | ||||
Assess | ||||||
Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 |
Heteromer P61769; | 2×FO4; 4×NAG; | ||||
Assess | ||||||
Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22 |
Heteromer P61769; | 1×NAG; 1×NAG; 1×NAG; 1×AGH; 2×PEG; 1×CL; 1×SO4; 1×BGC; | ||||
Assess | ||||||
Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5 |
Heteromer P61769; | 1×NAG; 1×NAG; 2×NAG; 5×SO4; 1×AGH; 5×CL; | ||||
Assess | ||||||
Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and V… |
Heteromer A0A0B4J240; K7N5M3; K7N5M4; P61769; | 1×NAG; 1×AGH; | ||||
Assess | ||||||
Crystal structure of human CD1d-alpha-Galactosylceramide in complex with semi-invariant NKT cell re… |
Heteromer P61769; | 1×NAG; 1×NAG; 1×AGH; 1×MG; | ||||
Assess | ||||||
Crystal structure of human CD1d-lysophosphatidylcholine |
Heteromer P61769; | 1×NAG; 1×LSC; 1×HEX; 3×SO4; 4×GOL; 1×UND; | ||||
Assess | ||||||
Crystal Structure of 9C2 TCR bound to CD1d |
Heteromer P0CF51; P61769; Q6PJ56; | 2×NAG; 1×NAG; 1×NAG; 1×BMA; 1×MG; 1×JLS; 1×CL; | ||||
Assess | ||||||
The crystal structure of human CD1d with and without alpha-Galactosylceramide |
Heteromer P61769; | 1×AGH; | ||||
Assess | ||||||
Crystal structure of human autoreactive-Valpha24 NKT TCR in complex with CD1d-beta-galactosylcerami… |
Heteromer P01848; P61769; | 1×GCY; | ||||
Assess | ||||||
Crystal structure of CD1d-lipid-antigen complexed with Beta-2-Microglobulin, NKT15 Alpha-Chain and … |
Heteromer P01848; P61769; | 1×NAG; 2×NAG; 1×AGH; | ||||
Assess | ||||||
The molecular bases of Delta/Alpha beta T cell-mediated antigen recognition. |
Heteromer P61769; | 1×NAG; 1×NAG; 1×NAG; 1×JLS; | ||||
Assess | ||||||
Ternary crystal structure of the human NKT TCR-CD1d-4'deoxy-alpha-galactosylceramide complex |
Heteromer P61769; | 2×NAG; 1×4GH; 1×MG; | ||||
Assess | ||||||
Crystal structure of a human Valpha24(-) NKT TCR in complex with CD1d/alpha-galactosylceramide |
Heteromer K7N5M3; K7N5M4; P61769; | 5×NAG; 1×AGH; 1×FUC; 2×GOL; | ||||
Assess | ||||||
Crystal structure of an iNKT TCR in complex with CD1d-lysophosphatidylcholine |
Heteromer P61769; | 1×NAG; 1×LSC; 1×HEX; 1×D12; 1×GOL; | ||||
Assess | ||||||
Ternary crystal structure of the human NKT TCR-CD1d-C20:2 complex |
Heteromer P61769; | 2×NAG; 1×DB3; 1×MG; | ||||
Assess | ||||||
Crystal structure of human TCR Alpha Chain-TRAV12-3, Beta Chain-TRBV6-5, Antigen-presenting molecul… |
Heteromer A0A0B4J271; A0A0K0K1A5; A0A5B9; P01848; P61769; | 2×NAG; 1×JLS; | ||||
Assess | ||||||
Structure of human CD1d-sulfatide |
Heteromer P01887; P11609; | 1×NAG; 1×CIS; | ||||
Assess | ||||||
Structure of the DP10.7 TCR with CD1d-sulfatide |
Heteromer P01887; P11609; Q6PJ56; | 3×NAG; 1×CIS; | ||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
4mng.1.B | monomer | 0.85 | 2×NAG; | 92.36 | ||
Assess |